Timolol Maleate Solution, Gel Forming / Drops
Product Images NDC 25021-008

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Timolol Maleate (NDC 25021-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tim06 0000 01)

Chemical structure diagram of Timolol Maleate, showing its molecular arrangement including the thiazole ring, morpholine ring, and the maleate part.*

FDA Label Image

Figure (Tim06 0000 02)

Two line graphs showing mean intraocular pressure (IOP) and standard deviation over 24 weeks by treatment group in a U.S. study. One graph represents IOP at trough (hour 0) and the other at peak (hour 2). Treatment groups compare Timolol Maleate Ophthalmic Gel Forming Solution 0.5% and Timolol Maleate Ophthalmic Solution 0.5% with IOP measured in mm Hg over time in weeks.*

FDA Label Image

Figure (Tim06 0000 03)

Two line graphs comparing Timolol Maleate Ophthalmic Gel Forming Solution 0.5% dosed once daily and Timolol Maleate Ophthalmic Solution 0.5% dosed twice daily over 24 weeks. The graphs plot intraocular pressure (mm Hg) on the y-axis versus weeks on the x-axis, reflecting measurements at trough (hour 0) and peak (hour 2) times. Error bars represent variability for each data point.*

FDA Label Image

Figure (Tim06 0000 04)

An instructional illustration showing a person holding an ophthalmic drop bottle near the eye, demonstrating the correct technique for administering eye drops. The image depicts the bottle tip positioned above the eye and a few drops being instilled.*

FDA Label Image

Figure (Tim06 0000 05)

An instructional illustration showing a hand holding an ophthalmic drop bottle positioned above an eye, demonstrating the proper technique for applying eye drops to the ocular surface.*

FDA Label Image

Figure (Tim06 0000 06)

An instructional illustration showing a person administering an ophthalmic drop by tilting the head back, holding the eye open with one hand, and applying the drop from a bottle held in the other hand. The diagram demonstrates proper technique for applying Timolol Maleate ophthalmic solution, gel forming drops.*

FDA Label Image

Package Label – Principal Display Panel – Bottle Label (Tim06 0000 07)

Label for Timolol Maleate Ophthalmic Gel Forming Solution 0.25% (2.5 mg/mL) in a 5 mL bottle. The label identifies it as sterile and for topical application in the eye. It includes dosage instructions and manufacturer information: Sagent Pharmaceuticals, Schaumburg, IL, Made in India.*

FDA Label Image

Package Label – Principal Display Panel – Bottle Label (Tim06 0000 08)

Packaging label for Timolol Maleate Ophthalmic Gel Forming Solution, 0.5% strength, in a 5 mL volume. The label shows it is a sterile gel-forming solution for topical application in the eye. The labeler is Sagent Pharmaceuticals. The label includes the NDC 25021-009-05 and usage instructions specifying the usual dosage as 1 drop in the affected eye once daily, with storage and handling instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.